Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome
Selective serotonin reuptake inhibitors (SSRI)-induced apathy syndrome occurs in 5–20% of patients taking these drugs.Objective: to investigate the possibility and advantages of switching patients with SSRI-induced apathy to treatment with a SSRI and norepinephrine reuptake inhibitor.Patients and me...
Main Authors: | V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2020-04-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1304 |
Similar Items
-
Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
by: Hashimoto T, et al.
Published: (2015-12-01) -
Safety of concomitant treatment with Non-Vitamin K Oral Anticoagulants and SSRI/SNRI antidepressants
by: Boguta Piotr, et al.
Published: (2018-12-01) -
Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
by: Thibault eRenoir
Published: (2013-04-01) -
SSRI use in pregnancy: Evaluating the risks and benefits
by: Elsa du Toit, et al.
Published: (2015-05-01) -
Serotonin Syndrome Due to Overdose Intake of SSRI
by: Yavuz Orak, et al.
Published: (2015-08-01)